Latest posts in

Videos

AJ Loiacono & Holly Maloney (Part 4): Regulatory Progress – The CAA & IRA
AJ Loiacono & Holly Maloney (Part 4): Regulatory Progress – The CAA & IRA

Capital Rx CEO AJ Loiacono discusses how regulatory progress may impact the PBM business with General Catalyst's Holly Maloney.

Read
AJ Loiacono & Holly Maloney (Part 3): Capital Rx’s Expansion into Medicare
AJ Loiacono & Holly Maloney (Part 3): Capital Rx’s Expansion into Medicare

Capital Rx CEO AJ Loiacono describes the importance of bringing a new system - JUDI® - to the market to process Medicare claims.

Read
AJ Loiacono & Holly Maloney (Part 2): Outlook for 2023 – What to Watch For
AJ Loiacono & Holly Maloney (Part 2): Outlook for 2023 – What to Watch For

Capital Rx CEO AJ Loiacono and General Catalyst's Holly Maloney share 5 predictions for 2023.

Read
AJ Loiacono & Holly Maloney (Part 1): Navigating 2022 - A Recap of Top Challenges Faced
AJ Loiacono & Holly Maloney (Part 1): Navigating 2022 - A Recap of Top Challenges Faced

Capital Rx CEO AJ Loiacono and General Catalyst's Holly Maloney discuss key investment and management challenges faced in 2022.

Read
ENGAGE at HLTH 2022 Replay: What should an ethical PBM look like?
ENGAGE at HLTH 2022 Replay: What should an ethical PBM look like?

What should an ethical PBM look like? Watch AJ Loiacono and MedCity's Arundhati Parmar at ENGAGE at HLTH 2022.

Read
Replay - Reviewing Drug Pricing Options: From AWP to AAC and Regulatory Impacts
Replay - Reviewing Drug Pricing Options: From AWP to AAC and Regulatory Impacts

Capital Rx President Matt Gibbs breaks down drug price indexes, including problems with them, and what plan sponsors/payers should be thinking and asking about during contracting.

Read
thINc360 PBM 2.0 Market Insight Panel; Taming the Prescription Drug Beast and Driving a Paradigm Shift with Alignment and Technology
thINc360 PBM 2.0 Market Insight Panel; Taming the Prescription Drug Beast and Driving a Paradigm Shift with Alignment and Technology

On May 23, 2022, Capital Rx’s Chief Growth Officer, Kristin Begley, was joined by an exceptional panel of experts on stage at thINc360.

Read
Next-Gen PBM Capital Rx Becomes a Tech Co: Inside New PBA Biz, $106M Series C & Big Plans with WTF Health
Next-Gen PBM Capital Rx Becomes a Tech Co: Inside New PBA Biz, $106M Series C & Big Plans with WTF Health

Thanks to Jessica DaMassa and WTF Health for having Capital Rx Co-Founder & CEO, AJ Loiacono, on for a great discussion about the evolution of the pharmacy benefit management (PBM) and pharmacy benefit administration (PBA) models!

Read